Background: Several biological age (BA) prediction models have been suggested with a variety of biomarkers. Valid models should be able to measure BA in a relatively short time period and predict subsequent physiological capability. Physiological and physical fitness variables have been shown to be distinctive markers for predicting BA and morbidity. The practical and noninvasive nature of such variables makes them useful as clinical assessment tools in estimating BA for in-depth diagnosis and corresponding intervention. Objective: To identify, develop and evaluate biomarkers and BA prediction models and validate their clinical usefulness for the practical diagnosis of functional aging. Methods: Fourteen variables were measured in 3,112 male and 1,233 female participants aged 30 and older between the years 2004 and 2007. Through a series of parsimonious stepwise elimination processes, two sets of 8 gender-specific variables were selected as candidate biomarkers for 1,604 men and 760 women. Principal component analysis, linear regression analysis and adjustment methods were further applied to obtain two sets of true BA (TBA) prediction models. The TBA models were examined for validity by comparing TBA to the corresponding chronological age (CA) with clinical risk factors. Results: TBA prediction models with r2 values of 0.638 and 0.672 were developed, each unique to men and women, respectively. The overall mean TBA and CA of the participants were 53.9 and 51.8 years, respectively, with a marginal difference of –2.1 and –1.3 years. The regression slopes or rates of TBA as a function of CA were 1.00 and 1.28 for men and women with r values of 0.799 and 0.820 (p < 0.001), respectively. In comparing TBA to CA rates between healthy and clinical risk groups, both sarcopenic and obese groups showed significant increases in TBA. Conclusions: The selected biomarkers encompass various complex physiopathological factors related to intrinsic and extrinsic physiological and functional aging. The BA prediction models based on the selected biomarkers could be practical in assessing BA for Korean adults.

Keywords:
Biological age, Chronological age, Physiological age, Physical fitness, Principal component analysis
1.
Baker GT 3rd, Sprott RL: Biomarkers of aging. Exp Gerontol 1988;23:223–239.
2.
Costa PT, McCrae RR: Concepts of functional or biological age: a critical view; in Andres R, Bierman E, Hazzard W (eds): Principles of Geriatric Medicine. New York, McGraw-Hill, 1985, pp 30–37.
3.
Ortega FB, Ruiz JR, Castillo MJ, Sjostrom M: Physical fitness in childhood and adolescence: a powerful marker of health. Int J Obes (Lond) 2008;32:1–11.
4.
Park JH, Cho BL, Kwon HT, Lee CM: Developing a biological age assessment equation using principal component analysis and clinical biomarkers of aging in Korean men. Arch Gerontol Geriatr 2009;49:7–12.
5.
Hofecker G, Skalicky M, Kment A, Niedermuller H: Models of the biological age of the rat. I. A factor model of age parameters. Mech Ageing Dev 1980;14:345–359.
6.
Ingram DK, Nakamura E, Smucny D, Roth GS, Lane MA: Strategy for identifying biomarkers of aging in long-lived species. Exp Gerontol 2001;36:1025–1034.
7.
Kokkinos P, Myers J, Faselis C, Panagiotakos DB, Doumas M, Pittaras A, Manolis A, Kokkinos JP, Karasik P, Greenberg M, Papademetriou V, Fletcher R: Exercise capacity and mortality in older men: a 20-year follow-up study. Circulation 2010;122:790–797.
8.
Stewart KJ: Physical activity and aging. Ann NY Acad Sci 2005;1055:193–206.
9.
Bae CY, Kang YG, Kim S, Cho C, Kang HC, Yu BY, Lee SW, Cho KH, Lee DC, Lee K, Kim JS, Shin KK: Development of models for predicting biological age (BA) with physical, biochemical, and hormonal parameters. Arch Gerontol Geriatr 2008;47:253–265.
10.
American College of Sports Medicine: ACSM’s Guidelines for Exercise Testing and Prescription, ed 8. Philadelphia, Lippincott, Williams & Wilkins, 2010.
11.
American Thoracic Society: Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107–1136.
12.
Ueno LM, Yamashita Y, Moritani T, Nakamura E: Biomarkers of aging in women and the rate of longitudinal changes. J Physiol Anthropol Appl Human Sci 2003;22:37–46.
13.
WHO Expert Consultation: Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157–163.
14.
Wang Z, Ma J, Si D: Optimal cut-off values and population means of waist circumference in different populations. Nutr Res Rev 2010;23:191–199.
15.
Arnett SW, Laity JH, Agrawal SK, Cress ME: Aerobic reserve and physical functional performance in older adults. Age Ageing 2008;37:384–389.
16.
Nakamura E, Lane MA, Roth GS, Ingram DK: A strategy for identifying biomarkers of aging: further evaluation of hematology and blood chemistry data from a calorie restriction study in rhesus monkeys. Exp Gerontol 1998;33:421–443.
17.
Guttman L: General theory and methods for matrix factoring. Psychometrika 1967;9:1–16.
18.
Bai X, Han L, Liu Q, Shan H, Lin H, Sun X, Chen XM: Evaluation of biological aging process – a population-based study of healthy people in China. Gerontology 2010;56:129–140.
19.
Webster IW, Logie AR: A relationship between functional age and health status in female subjects. J Gerontol 1976;31:546–550.
20.
Dubina TL, Dyundikova VA, Zhuk EV: Biological age and its estimation. II. Assessment of biological age of albino rats by multiple regression analysis. Exp Gerontol 1983;18:5–18.
21.
Dubina TL, Mints A, Zhuk EV: Biological age and its estimation. III. Introduction of a correction to the multiple regression model of biological age in cross-sectional and longitudinal studies. Exp Gerontol 1984;19:133–143.
22.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinkova E, Vandewoude M, Zamboni M: Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412–423.
23.
Fulop T, Larbi A, Witkowski JM, McElhaney J, Loeb M, Mitnitski A, Pawelec G: Aging, frailty and age-related diseases. Biogerontology 2010;11:547–563.
24.
Ryall JG, Schertzer JD, Lynch GS: Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology 2008;9:213–228.
25.
Abellan van Kan G, Rolland YM, Morley JE, Vellas B: Frailty: toward a clinical definition. J Am Med Dir Assoc 2008;9:71–72.
26.
Lee MS, Tanaka K, Nakagaichi M, Nakadomo F, Watanabe K, Takeshima N, Hiyama T, Chodzko-Zaiko W: The relative utility of health-related fitness tests and skilled motor performance tests as measure of biological age in Japanese men. Appl Human Sci 1996;15:97–104.
27.
Caspersen CJ, Powell KE, Christenson GM: Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 1985;100:126–131.
28.
Ludwig FC, Smoke ME: The measurement of biological age. Exp Aging Res 1980;6:497–522.
29.
Kimura M, Mizuta C, Yamada Y, Okayama Y, Nakamura E: Constructing an index of physical fitness age for Japanese elderly based on 7-year longitudinal data: sex differences in estimated physical fitness age. Age (Dordr) 2012;34:203–214.
30.
Gray L, Hart CL, Smith GD, Batty GD: What is the predictive value of established risk factors for total and cardiovascular disease mortality when measured before middle age? Pooled analyses of two prospective cohort studies from Scotland. Eur J Cardiovasc Prev Rehabil 2010;17:106–112.
31.
Hole DJ, Watt GC, Davey-Smith G, Hart CL, Gillis CR, Hawthorne VM: Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ 1996;313:711–715, discussion 715–716.
32.
Cohen BH: Chronic obstructive pulmonary disease: a challenge in genetic epidemiology. Am J Epidemiol 1980;112:274–288.
33.
Sturnieks DL, St George R, Lord SR: Balance disorders in the elderly. Neurophysiol Clin 2008;38:467–478.
34.
Lord SR, Dayhew J: Visual risk factors for falls in older people. J Am Geriatr Soc 2001;49:508–515.
35.
Ruff RM, Parker SB: Gender- and age-specific changes in motor speed and eye-hand coordination in adults: normative values for the finger tapping and grooved pegboard tests. Percept Mot Skills 1993;76:1219–1230.
36.
Smith CD, Umberger GH, Manning EL, Slevin JT, Wekstein DR, Schmitt FA, Markesbery WR, Zhang Z, Gerhardt GA, Kryscio RJ, Gash DM: Critical decline in fine motor hand movements in human aging. Neurology 1999;53:1458–1461.
37.
Hagstromer M, Oja P, Sjostrom M: Physical activity and inactivity in an adult population assessed by accelerometry. Med Sci Sports Exerc 2007;39:1502–1508.
38.
Kell RT, Bell G, Quinney A: Musculoskeletal fitness, health outcomes and quality of life. Sports Med 2001;31:863–873.
39.
Intolo P, Milosavljevic S, Baxter DG, Carman AB, Pal P, Munn J: The effect of age on lumbar range of motion: a systematic review. Man Ther 2009;14:596–604.
40.
McHugh MP, Magnusson SP, Gleim GW, Nicholas JA: Viscoelastic stress relaxation in human skeletal muscle. Med Sci Sports Exerc 1992;24:1375–1382.
41.
Mendelsohn ME, Karas RH: Molecular and cellular basis of cardiovascular gender differences. Science 2005;308:1583–1587.
42.
Mercuro G, Deidda M, Piras A, Dessalvi CC, Maffei S, Rosano GM: Gender determinants of cardiovascular risk factors and diseases. J Cardiovasc Med (Hagerstown) 2010;11:207–220.
43.
Ghandehari H, Le V, Kamal-Bahl S, Bassin SL, Wong ND: Abdominal obesity and the spectrum of global cardiometabolic risks in US adults. Int J Obes (Lond) 2009;33:239–248.
44.
Janssen I: Influence of age on the relation between waist circumference and risk markers. Nutrition, metabolism, and cardiovascular disease. Nutr Metab Cardiovasc Dis 2009;19:163–169.
45.
Rothman KJ: BMI-related errors in the measurement of obesity. Int J Obes (Lond) 2008;32(suppl 3):S56–S59.
46.
Yashin AI, Ukraintseva SV, Arbeev KG, Akushevich I, Arbeeva LS, Kulminski AM: Maintaining physiological state for exceptional survival: what is the normal level of blood glucose and does it change with age? Mech Ageing Dev 2009;130:611–618.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.